Document is current
Any future updates will be listed below
-
Authors
Anwar, Faheem
Grech, Olivia
Mugo, Caroline W.
Roberts, James A.
Hubbard, Jessica C.
Thomas, Chloe N.
Sinclair, Alexandra J.
Hill, Lisa J.
-
Funding
Funding for this research was provided by:
Sir Arthur Thomson Trust
Sir Jules Thorn Charitable Trust (Award for Biomedical Science)
Sir Jules Thorn Charitable Trust (Award for Biomedical Science)
Sir Jules Thorn Charitable Trust (Award for Biomedical Science)
Department of Defence, United States (mTBI-PREDICT)
Department of Defence, United States (mTBI-PREDICT)
NIHR Birmingham Biomedical Research Centre
- License Information
-
More Information
Article History
Received: 25 April 2025
Accepted: 25 June 2025
First Online: 9 July 2025
Declarations
:
: Not applicable.
: Not applicable.
: OG reports consulting fees from Invex Therapeutics unrelated to this research. AJS reports has consulted for Novartis, AbbVie, Vertex and Orion Pharma and speaker fees from Teva Uk and Novartis. She was previously a Director and Chief Scientific Officer (CSO) with shares at Invex Therapeutics.
